Global Intelligent Asthma Monitoring Devices Market
Global Intelligent Asthma Monitoring Devices Market

Intelligent Asthma Monitoring Devices Comprehensive Study by Type (Wearable Asthma Monitoring Devices, Smart Inhalers), Application (Hospitals, Clinics, Home Use) Players and Region - Global Market Outlook to 2026

Intelligent Asthma Monitoring Devices Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Nov 2021 Edition 247 Pages 174 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Intelligent Asthma Monitoring Devices Market Overview:
Intelligent Asthma Monitoring Device is used to monitor asthma to avoid attacks and related morbidity. Asthma management requires patients' active commitment to engage in self-monitoring routines. The rise in air pollution is fueling the global market for intelligent asthma monitoring devices. Increased asthma susceptibility due to indoor air pollution, as well as an alarming rise in the global prevalence of COPD and asthma, are projected to drive market growth.

Growth Drivers
  • Rise in Allergic Reactions toward Pollen, Dust, and Other Allergens
  • Increasing Prevalence Of COPD & Asthma

Roadblocks
  • Accuracy and Reliability of the Device

Opportunities
  • High Demand from Emerging Economies
  • Advancements in the Intelligent Asthma Monitoring Devices

Challenges
  • Lack of Awareness


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Adherium Limited (New Zealand), AstraZeneca (United Kingdom), Cohero Health (United States), GlaxoSmithKline plc (United Kingdom), Health Care Originals (United States), Koninklijke Philips N.V (Netherlands), Propeller Health (United States), Teva Pharmaceutical Industries Ltd. (Israel), Vectura Group plc (United Kingdom) and Volansys Technologies (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Intelligent Asthma Monitoring Devices market by 2026.

Latest Market Insights:
On MAY 24 2019, Apple buys Tueo Health, which was working on a solution to help parents monitor asthma symptoms in children using a mobile app and commercial breathing sensors.

What Can be Explored with the Intelligent Asthma Monitoring Devices Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Intelligent Asthma Monitoring Devices Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Intelligent Asthma Monitoring Devices
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Intelligent Asthma Monitoring Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Intelligent Asthma Monitoring Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Manufacturers of Intelligent Asthma Monitoring Device, Distributors and Suppliers of Intelligent Asthma Monitoring Device, Public and Private Physicians, Clinical Laboratories, Healthcare Institutions and Research Firms.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Intelligent Asthma Monitoring Devices Market?
The Intelligent Asthma Monitoring Devices market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Intelligent Asthma Monitoring Devices Market?
Top performing companies in the Global Intelligent Asthma Monitoring Devices market are Adherium Limited (New Zealand), AstraZeneca (United Kingdom), Cohero Health (United States), GlaxoSmithKline plc (United Kingdom), Health Care Originals (United States), Koninklijke Philips N.V (Netherlands), Propeller Health (United States), Teva Pharmaceutical Industries Ltd. (Israel), Vectura Group plc (United Kingdom) and Volansys Technologies (United States), to name a few.

3. What trending factors would impact Intelligent Asthma Monitoring Devices Market growth most?
"Growth in the Number of Phone-Based Apps and Smart Inhalers" is seen as one of major influencing trends for Intelligent Asthma Monitoring Devices Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Type
  • Wearable Asthma Monitoring Devices
  • Smart Inhalers
By Application
  • Hospitals
  • Clinics
  • Home Use
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Allergic Reactions toward Pollen, Dust, and Other Allergens
      • 3.2.2. Increasing Prevalence Of COPD & Asthma
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness
    • 3.4. Market Trends
      • 3.4.1. Growth in the Number of Phone-Based Apps and Smart Inhalers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Intelligent Asthma Monitoring Devices, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Intelligent Asthma Monitoring Devices (Value)
      • 5.2.1. Global Intelligent Asthma Monitoring Devices by: Type (Value)
        • 5.2.1.1. Wearable Asthma Monitoring Devices
        • 5.2.1.2. Smart Inhalers
      • 5.2.2. Global Intelligent Asthma Monitoring Devices by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Home Use
      • 5.2.3. Global Intelligent Asthma Monitoring Devices Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Intelligent Asthma Monitoring Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Adherium Limited (New Zealand)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AstraZeneca (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cohero Health (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GlaxoSmithKline plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Health Care Originals (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Koninklijke Philips N.V (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Propeller Health (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Vectura Group plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Volansys Technologies (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Intelligent Asthma Monitoring Devices Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Intelligent Asthma Monitoring Devices (Value)
      • 7.2.1. Global Intelligent Asthma Monitoring Devices by: Type (Value)
        • 7.2.1.1. Wearable Asthma Monitoring Devices
        • 7.2.1.2. Smart Inhalers
      • 7.2.2. Global Intelligent Asthma Monitoring Devices by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Home Use
      • 7.2.3. Global Intelligent Asthma Monitoring Devices Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Intelligent Asthma Monitoring Devices: by Type(USD Million)
  • Table 2. Intelligent Asthma Monitoring Devices Wearable Asthma Monitoring Devices , by Region USD Million (2015-2020)
  • Table 3. Intelligent Asthma Monitoring Devices Smart Inhalers , by Region USD Million (2015-2020)
  • Table 4. Intelligent Asthma Monitoring Devices: by Application(USD Million)
  • Table 5. Intelligent Asthma Monitoring Devices Hospitals , by Region USD Million (2015-2020)
  • Table 6. Intelligent Asthma Monitoring Devices Clinics , by Region USD Million (2015-2020)
  • Table 7. Intelligent Asthma Monitoring Devices Home Use , by Region USD Million (2015-2020)
  • Table 8. South America Intelligent Asthma Monitoring Devices, by Country USD Million (2015-2020)
  • Table 9. South America Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 10. South America Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 11. Brazil Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 12. Brazil Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 13. Argentina Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 14. Argentina Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 15. Rest of South America Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 16. Rest of South America Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 17. Asia Pacific Intelligent Asthma Monitoring Devices, by Country USD Million (2015-2020)
  • Table 18. Asia Pacific Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 19. Asia Pacific Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 20. China Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 21. China Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 22. Japan Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 23. Japan Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 24. India Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 25. India Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 26. South Korea Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 27. South Korea Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 28. Taiwan Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 29. Taiwan Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 30. Australia Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 31. Australia Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 32. Rest of Asia-Pacific Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 34. Europe Intelligent Asthma Monitoring Devices, by Country USD Million (2015-2020)
  • Table 35. Europe Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 36. Europe Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 37. Germany Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 38. Germany Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 39. France Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 40. France Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 41. Italy Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 42. Italy Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 43. United Kingdom Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 44. United Kingdom Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 45. Netherlands Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 46. Netherlands Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 47. Rest of Europe Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 48. Rest of Europe Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 49. MEA Intelligent Asthma Monitoring Devices, by Country USD Million (2015-2020)
  • Table 50. MEA Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 51. MEA Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 52. Middle East Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 53. Middle East Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 54. Africa Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 55. Africa Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 56. North America Intelligent Asthma Monitoring Devices, by Country USD Million (2015-2020)
  • Table 57. North America Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 58. North America Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 59. United States Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 60. United States Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 61. Canada Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 62. Canada Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 63. Mexico Intelligent Asthma Monitoring Devices, by Type USD Million (2015-2020)
  • Table 64. Mexico Intelligent Asthma Monitoring Devices, by Application USD Million (2015-2020)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Intelligent Asthma Monitoring Devices: by Type(USD Million)
  • Table 76. Intelligent Asthma Monitoring Devices Wearable Asthma Monitoring Devices , by Region USD Million (2021-2026)
  • Table 77. Intelligent Asthma Monitoring Devices Smart Inhalers , by Region USD Million (2021-2026)
  • Table 78. Intelligent Asthma Monitoring Devices: by Application(USD Million)
  • Table 79. Intelligent Asthma Monitoring Devices Hospitals , by Region USD Million (2021-2026)
  • Table 80. Intelligent Asthma Monitoring Devices Clinics , by Region USD Million (2021-2026)
  • Table 81. Intelligent Asthma Monitoring Devices Home Use , by Region USD Million (2021-2026)
  • Table 82. South America Intelligent Asthma Monitoring Devices, by Country USD Million (2021-2026)
  • Table 83. South America Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 84. South America Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 85. Brazil Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 86. Brazil Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 87. Argentina Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 88. Argentina Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 89. Rest of South America Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 90. Rest of South America Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 91. Asia Pacific Intelligent Asthma Monitoring Devices, by Country USD Million (2021-2026)
  • Table 92. Asia Pacific Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 93. Asia Pacific Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 94. China Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 95. China Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 96. Japan Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 97. Japan Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 98. India Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 99. India Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 100. South Korea Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 101. South Korea Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 102. Taiwan Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 103. Taiwan Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 104. Australia Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 105. Australia Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 106. Rest of Asia-Pacific Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 107. Rest of Asia-Pacific Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 108. Europe Intelligent Asthma Monitoring Devices, by Country USD Million (2021-2026)
  • Table 109. Europe Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 110. Europe Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 111. Germany Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 112. Germany Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 113. France Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 114. France Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 115. Italy Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 116. Italy Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 117. United Kingdom Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 118. United Kingdom Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 119. Netherlands Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 120. Netherlands Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 121. Rest of Europe Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 122. Rest of Europe Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 123. MEA Intelligent Asthma Monitoring Devices, by Country USD Million (2021-2026)
  • Table 124. MEA Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 125. MEA Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 126. Middle East Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 127. Middle East Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 128. Africa Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 129. Africa Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 130. North America Intelligent Asthma Monitoring Devices, by Country USD Million (2021-2026)
  • Table 131. North America Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 132. North America Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 133. United States Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 134. United States Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 135. Canada Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 136. Canada Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 137. Mexico Intelligent Asthma Monitoring Devices, by Type USD Million (2021-2026)
  • Table 138. Mexico Intelligent Asthma Monitoring Devices, by Application USD Million (2021-2026)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Intelligent Asthma Monitoring Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Intelligent Asthma Monitoring Devices: by Application USD Million (2015-2020)
  • Figure 6. South America Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 7. Asia Pacific Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 8. Europe Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 9. MEA Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 10. North America Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 11. Global Intelligent Asthma Monitoring Devices share by Players 2020 (%)
  • Figure 12. Global Intelligent Asthma Monitoring Devices share by Players (Top 3) 2020(%)
  • Figure 13. Global Intelligent Asthma Monitoring Devices share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Adherium Limited (New Zealand) Revenue, Net Income and Gross profit
  • Figure 16. Adherium Limited (New Zealand) Revenue: by Geography 2020
  • Figure 17. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. AstraZeneca (United Kingdom) Revenue: by Geography 2020
  • Figure 19. Cohero Health (United States) Revenue, Net Income and Gross profit
  • Figure 20. Cohero Health (United States) Revenue: by Geography 2020
  • Figure 21. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 23. Health Care Originals (United States) Revenue, Net Income and Gross profit
  • Figure 24. Health Care Originals (United States) Revenue: by Geography 2020
  • Figure 25. Koninklijke Philips N.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Koninklijke Philips N.V (Netherlands) Revenue: by Geography 2020
  • Figure 27. Propeller Health (United States) Revenue, Net Income and Gross profit
  • Figure 28. Propeller Health (United States) Revenue: by Geography 2020
  • Figure 29. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 30. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 31. Vectura Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Vectura Group plc (United Kingdom) Revenue: by Geography 2020
  • Figure 33. Volansys Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 34. Volansys Technologies (United States) Revenue: by Geography 2020
  • Figure 35. Global Intelligent Asthma Monitoring Devices: by Type USD Million (2021-2026)
  • Figure 36. Global Intelligent Asthma Monitoring Devices: by Application USD Million (2021-2026)
  • Figure 37. South America Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 38. Asia Pacific Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 39. Europe Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 40. MEA Intelligent Asthma Monitoring Devices Share (%), by Country
  • Figure 41. North America Intelligent Asthma Monitoring Devices Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Adherium Limited (New Zealand)
  • AstraZeneca (United Kingdom)
  • Cohero Health (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Health Care Originals (United States)
  • Koninklijke Philips N.V (Netherlands)
  • Propeller Health (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Vectura Group plc (United Kingdom)
  • Volansys Technologies (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation